BIO-key International
BKYI
10 hedge funds and large institutions have $99.5K invested in BIO-key International in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
42% more capital invested
Capital invested by funds: $69.8K → $99.5K (+$29.7K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0.05% more ownership
Funds ownership: 0.15% → 0.2% (+0.05%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.1K |
| 3 |
Renaissance Technologies
New York
|
+$16K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$14.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$23.9K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$11K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9.93K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$23 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$1 |
BKYI Hedge Fund Activity: Q3 2025 in Review
10 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2025, worth a combined $99.5K — up 42% from $69.8K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BKYI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $28.8K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $23.9K sold.
- 10 institutional investors held BIO-key International (BKYI) as of Q3 2025, up from 8 in Q2 2025.
- Funds reported $99.5K of BIO-key International stock for Q3 2025, up 42% quarter-over-quarter.
- 4 funds opened new BIO-key International positions in Q3 2025 and 2 closed out, a net change of +2 holders.
- The largest BIO-key International buyer in Q3 2025 was Vanguard Group, an estimated $28.8K added.
- The largest BIO-key International seller in Q3 2025 was Two Sigma Securities, an estimated $23.9K sold.
Based on aggregated 13F filings for Q3 2025.